[1]
“Cutaneous manifestations of interferon alfa and ribavirin for hepatitis C”, J Pak Assoc Dermatol, vol. 18, no. 1, pp. 14–20, Dec. 2016, doi: 10.66344/jpad.18.1.2008.560.